Publications by authors named "Borˇivoj Vojtesek"

Article Synopsis
  • - TP73, part of the TP53 gene family, produces different protein variants (TAp73 and ΔTAp73) with opposing functions through various genetic mechanisms.
  • - Newly developed antibodies for these p73 variants reveal that TAp73 is present in multiciliated epithelial cells, while ΔTAp73 marks non-proliferative basal cells in squamous epithelium.
  • - In cervical squamous cell carcinomas, p73α is commonly expressed and linked to lower tumor grades, whereas TAp73 appears less frequently and does not show significant associations with cancer characteristics.
View Article and Find Full Text PDF

Readthrough of a translation termination codon is regulated by ribosomal A site recognition and insertion of near-cognate tRNAs. Small molecules exist that mediate incorporation of amino acids at the stop codon and production of full-length, often functional protein but defining the actual amino acid that is incorporated remains a challenging area. Herein, we report on the development a human cell model that can be used to determine whether rules can be developed using mass spectrometry that define the type of amino acid that is placed at a premature termination codon (PTC) during readthrough mediated by an aminoglycoside.

View Article and Find Full Text PDF

Stress responses play a vital role in cellular survival against environmental challenges, often exploited by cancer cells to proliferate, counteract genomic instability, and resist therapeutic stress. Heat shock factor protein 1 (HSF1), a central transcription factor in stress response pathways, exhibits markedly elevated activity in cancer. Despite extensive research into the transcriptional role of HSF1, the mechanisms underlying its activation remain elusive.

View Article and Find Full Text PDF

The p53 family of proteins evolved from a common ancestor into three separate genes encoding proteins that act as transcription factors with distinct cellular roles. Isoforms of each member that lack specific regions or domains are suggested to result from alternative transcription start sites, alternative splicing or alternative translation initiation, and have the potential to exponentially increase the functional repertoire of each gene. However, evidence supporting the presence of individual protein variants at functional levels is often limited and is inferred by mRNA detection using highly sensitive amplification techniques.

View Article and Find Full Text PDF
Article Synopsis
  • PD-L1 expression is a key factor in how cancer cells escape the immune system, and targeting the PD-L1/PD1 interaction is a common immunotherapy for melanoma patients, although many still do not respond.
  • This study focused on different human melanoma cell lines with varying p53 status to examine the relationship between p53, PD-L1, and immune responses, using techniques like immunoblotting and flow cytometry.
  • Results indicated that the loss of p53 impacts PD-L1 levels through the regulation of IRF1 and SOX10, and influences the ability of natural killer (NK) cells to kill tumor cells, highlighting the complex interplay of these factors in cancer immune response.
View Article and Find Full Text PDF
Article Synopsis
  • Monoclonal antibodies that target immune checkpoints are changing cancer treatment, but their effectiveness varies and can lead to unexpected issues like hyperprogression.
  • Current animal research models, especially mice, don’t accurately reflect the human immune system and patient differences, creating a need for better models.
  • This study introduces two new antibodies that effectively target canine PD-1, offering valuable tools for canine cancer research and potential new treatments for dogs with cancer.
View Article and Find Full Text PDF

Efforts to address the poor prognosis associated with esophageal adenocarcinoma (EAC) have been hampered by a lack of biomarkers to identify early disease and therapeutic targets. Despite extensive efforts to understand the somatic mutations associated with EAC over the past decade, a gap remains in understanding how the atlas of genomic aberrations in this cancer impacts the proteome and which somatic variants are of importance for the disease phenotype. We performed a quantitative proteomic analysis of 23 EACs and matched adjacent normal esophageal and gastric tissues.

View Article and Find Full Text PDF

mRNAs containing premature stop codons are responsible for various genetic diseases as well as cancers. The truncated proteins synthesized from these aberrant mRNAs are seldom detected due to the nonsense-mediated mRNA decay (NMD) pathway. Such a surveillance mechanism detects most of these aberrant mRNAs and rapidly destroys them from the pool of mRNAs.

View Article and Find Full Text PDF
Article Synopsis
  • TGFβ plays a significant role in inflammation, wound healing, and cancer, acting as a tumor suppressor in squamous cell carcinoma (SCC), which is linked to high ΔNp63 levels.
  • Research shows that TGFβ selectively increases ΔNp63 protein in healthy cells via canonical signaling, but the relationship between mRNA levels and protein is complicated, showing initial increases followed by later declines.
  • The interactions between TGFβ and p63 may affect epithelial-to-mesenchymal transition and influence tumor behavior and treatment responses in SCC.
View Article and Find Full Text PDF

Interferon induced transmembrane proteins (IFITMs) play a dual role in the restriction of RNA viruses and in cancer progression, yet the mechanism of their action remains unknown. Currently, there is no data about the basic biochemical features or biophysical properties of the IFITM1 protein. In this work, we report on description and biochemical characterization of three conformational variants/oligomeric species of recombinant IFITM1 protein derived from an expression system.

View Article and Find Full Text PDF

Breast cancer is a highly heterogeneous disease. Its intrinsic subtype classification for diagnosis and choice of therapy traditionally relies on the presence of characteristic receptors. Unfortunately, this classification is often not sufficient for precise prediction of disease prognosis and treatment efficacy.

View Article and Find Full Text PDF

Breast cancers are a heterogeneous group of tumors classified according to their histological growth patterns and receptor expression characteristics. Intratumor heterogeneity also exists, with subpopulations of cells with different phenotypes found in individual cancers, including cells with stem or progenitor cell properties. At least two types of breast cancer stem cells (CSCs) exist, the epithelial and the basal/mesenchymal subtypes, although how these phenotypes are controlled is unknown.

View Article and Find Full Text PDF

Activation of p53 by small molecule MDM2 inhibitors can induce cell cycle arrest or death in p53 wildtype cancer cells. However, cancer cells exposed to hypoxia can develop resistance to other small molecules, such as chemotherapies, that activate p53. Here, we evaluated whether hypoxia could render cancer cells insensitive to two MDM2 inhibitors with different potencies, nutlin-3a and navtemadlin.

View Article and Find Full Text PDF

Defining dynamic protein-protein interactions in the ubiquitin conjugation reaction is a challenging research area. Generating peptide aptamers that target components such as ubiquitin itself, E1, E2, or E3 could provide tools to dissect novel features of the enzymatic cascade. Next-generation deep sequencing platforms were used to identify peptide sequences isolated from phage-peptide libraries screened against Ubiquitin and its ortholog NEDD8.

View Article and Find Full Text PDF

Interferons (IFNs) are important cytokines that regulate immune responses through the activation of hundreds of genes, including interferon-induced transmembrane proteins (IFITMs). This evolutionarily conserved protein family includes five functionally active homologs in humans. Despite the high sequence homology, IFITMs vary in expression, subcellular localization and function.

View Article and Find Full Text PDF

Signal transducer and activator of transcription 3 (Stat3) is responsible for many aspects of normal development and contributes to the development and progression of cancer through regulating epithelial cell identity and cancer stem cells. In breast cancer, Stat3 is associated with triple-negative breast cancers (TNBC) and its function has been related to the activation of p63, itself a marker of basal-like TNBC and a master regulator of stem cell activities. Stat3 activation is controlled by dual phosphorylation at tyrosine 705 (pTyr705) and serine 727 (pSer727), although it is unclear whether these have equivalent effects, and whether they are related or independent events.

View Article and Find Full Text PDF
Article Synopsis
  • DNA and RNA binding proteins (DRBPs) are key regulators of cellular processes and play a vital role in gene expression and nucleotide metabolism across all life forms.
  • Dysregulation of these proteins can lead to various diseases, particularly cancer, as they often have overlapping functions and are crucial for understanding the molecular mechanisms of tumor development.
  • The review highlights different classes of DRBPs, their biochemical properties, and their potential as therapeutic targets in cancer treatment by analyzing existing protein databases and identifying specific DRBPs associated with various cancer types.
View Article and Find Full Text PDF

The IFITM restriction factors play a role in cancer cell progression through undefined mechanisms. We investigate new protein-protein interactions for IFITM1/3 in the context of cancer that would shed some light on how IFITM1/3 attenuate the expression of targeted proteins such as HLA-B. SBP-tagged IFITM1 protein was used to identify an association of IFITM1 protein with the SRSF1 splicing factor and transporter of mRNA to the ribosome.

View Article and Find Full Text PDF

Objectives: The aim of this study was the analysis of WNT10A variants in seven families of probands with various forms of tooth agenesis and self-reported family history of cancer.

Materials And Methods: We enrolled 60 young subjects (aged 13 to 17) from the Czech Republic with various forms of tooth agenesis. Dental phenotypes were assessed using Planmeca ProMax 3D (Planmeca Oy, Finland) with Planmeca Romexis software (version 2.

View Article and Find Full Text PDF

The gene encodes two major protein variants; TAp63 contains a p53-like transcription domain and consequently has tumor suppressor activities whereas ΔNp63 lacks this domain and acts as an oncogene. The two variants show distinct expression patterns in normal tissues and tumors, with lymphocytes and lymphomas/leukemias expressing TAp63, and basal epithelial cells and some carcinomas expressing high levels of ΔNp63, most notably squamous cell carcinomas (SCC). Whilst the transcriptional functions of TAp63 and ΔNp63 isoforms are known, the mechanisms involved in their regulation are poorly understood.

View Article and Find Full Text PDF

HDMX and its homologue HDM2 are two essential proteins for the cell; after genotoxic stress, both are phosphorylated near to their RING domain, specifically at serine 403 and 395, respectively. Once phosphorylated, both can bind the p53 mRNA and enhance its translation; however, both recognize p53 protein and provoke its degradation under normal conditions. HDM2 has been well-recognized as an E3 ubiquitin ligase, whereas it has been reported that even with the high similarity between the RING domains of the two homologs, HDMX does not have the E3 ligase activity.

View Article and Find Full Text PDF

Disordered proteins pose a major challenge to structural biology. A prominent example is the tumor suppressor p53, whose low expression levels and poor conformational stability hamper the development of cancer therapeutics. All these characteristics make it a prime example of "life on the edge of solubility.

View Article and Find Full Text PDF

Background: ΔNp63 overexpression is a common event in squamous cell carcinoma (SCC) that contributes to tumorigenesis, making ΔNp63 a potential target for therapy.

Methods: We created inducible TP63-shRNA cells to study the effects of p63-depletion in SCC cell lines and non-malignant HaCaT keratinocytes. DNA damaging agents, growth factors, signaling pathway inhibitors, histone deacetylase inhibitors, and metabolism-modifying drugs were also investigated for their ability to influence ΔNp63 protein and mRNA levels.

View Article and Find Full Text PDF